AB141520
Butyrolactone I, ATP-competitive cyclin-dependent kinase (CDK) inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 424.4 Da, Purity >97%. Cell permeable, selective, ATP-competitive CDK inhibitor. Inhibits CDC2, CDK2, and CDK5. Inhibits the cell cycle at G1/S and G2/M. Apoptotic and antitumor activity.
1 Images
- Chemical Structure
Lab
Chemical Structure - Butyrolactone I, ATP-competitive cyclin-dependent kinase (CDK) inhibitor (AB141520)
2D chemical structure image of ab141520, Butyrolactone I, ATP-competitive cyclin-dependent kinase (CDK) inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature cell biology 25:439-452 PubMed36732633
2023
Actin-driven chromosome clustering facilitates fast and complete chromosome capture in mammalian oocytes.
Applications
Unspecified application
Species
Unspecified reactive species
Katarina Harasimov,Julia Uraji,Eike Urs Mönnich,Zuzana Holubcová,Kay Elder,Martyn Blayney,Melina Schuh
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com